NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/24/2023
Back to search
Official data from USPTO
LAWRENCE DRUG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LAWRENCE DRUG
ST13
US500000076063710Class
42
Filing
76063710
Registration
2660237
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
01/24/2023
Trademark type
Word
Nice classes
42
Filing date
06/01/2000
Registration date
12/10/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2023
Last transaction
01/24/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/31/2000
First use in commerce
06/30/2001
Drawing code
1
Owner type
03
Owner location
Springfield, MO
Examiner
BRYAN JOHNSON, HELLEN
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Lawrence Drug, Incorporated
Representatives
Jonathan A. Bay Attorney at Law
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
PHARMACY SERVICESPROVIDING CUSTOMER PRESCRIPTION DRUG FULFILLMENT AND REFILL SERVICES
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
01/24/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/24/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
07/07/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/10/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/26/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/26/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/26/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
07/24/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/05/2010
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/24/2008
PLGL
ASSIGNED TO PARALEGAL
12/08/2008
ES8R
TEAS SECTION 8 RECEIVED
12/01/2008
CFIT
CASE FILE IN TICRS
01/04/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
12/10/2002
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/30/2002
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/24/2002
IUAF
USE AMENDMENT FILED
09/11/2002
EISU
TEAS STATEMENT OF USE RECEIVED
09/11/2002
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
06/25/2002
PUBO
PUBLISHED FOR OPPOSITION
04/02/2002
NPUB
NOTICE OF PUBLICATION
03/13/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2001
CNRT
NON-FINAL ACTION MAILED
12/11/2000
DOCK
ASSIGNED TO EXAMINER
12/04/2000
Continuous trademark protection
Get notified about every new filing that threatens LAWRENCE DRUG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.